Woodline Partners LP Lowers Stock Holdings in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)
Woodline Partners LP cut its stake in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 81.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 229,376 shares of the biopharmaceutical company’s stock after selling 982,548 shares during the quarter. Woodline Partners […]
